The leading Russian Pharmaceutical conference

Announcement:

It is our great pleasure to invite you to attend Adam Smith Conferences' 16th Russian Pharmaceutical Forum, taking place, as always, in Saint-Petersburg, on 19-21 May 2010.
It is our great pleasure to invite you to attend Adam Smith Conferences' 16th Russian Pharmaceutical Forum, taking place, as always, in Saint-Petersburg, on 19-21 May 2010.

Russia's business environment has always been more volatile and unpredictable than in the more well-developed western counties, and with the recent introduction of new price control mechanisms, a promised ban on sales representatives, and intensified Government efforts to encourage further construction of manufacturing facilities within Russia - all market players need to be increasingly flexible and to effectively respond to market changes. Despite the current constraints in the sector, every company is looking for new opportunities that the evolving healthcare system might offer.

As a result , there has never been a better time to organise this Forum. Now, more than ever, it is vital that the industry decision-makers come together to discuss all the burning questions of the day, to compare experiences, share ideas for the future, and of course, to meet all the key people in the market!

REASONS WHY YOU CANNOT AFFORD TO MISS THE PHARMACEUTICAL INDUSTRY EVENT OF 2010:

• 50 + OUTSTANDING SPEAKER FACULTY, brining together senior executives from the leading and most dynamic local and international producers, distributors, retailers, government officials, business and legal experts

• 11 MULTI-SPEAKER SESSIONS providing information, which is not available anywhere else on the topics including:

Regulatory Issues in the pharmaceutical market
Strategic planning, commercial strategies and business models
Pricing, Reimbursement and Market Access
Distribution: Earnings, Challenges and Growth
Retail - The Possible Development Scenarios
Sales Force Strategies
New! Special Focus: Healthcare and OTC Products
Effective marketing strategies

• 350 ATENDEES ANNUALLY from 30 + countries, so you can register for the forum with confidence, knowing that this event is proven to deliver outstanding networking opportunities at the very highest level

• 15 YEARS OF EXPERIENCE IN THE MARKET AND TOP QUALITY REPUTATION: the Forum is now in its 16th year, and is long established as THE leading annual international gathering for the most senior professionals in the Russian Pharmaceutical Sector.

SPECIAL FEATURES for the Russian Pharmaceutical Forum 2010:

• ANALYTICAL THINK TANK: This think tank will feature trusted experts in the sector, representing the leading market research companies. The panel will analyse the current reform process and its effects on various segments of the industry, and will present a detailed statistical review of the key market segments, therapy areas, products and companies, as well as evaluating key drivers and impediments to future market development.

• INTERVIEW WITH A LEADING INDUSTRY EXPERT - we are currently inviting one of the leading CEOs in the industry to participate in a live interview, to share his views on the current problems in the sector, and to evaluate industry development prospects in the near future, in an interactive and informative way

• CEO PANEL: Achieving Growth in a Volatile Climate
This panel featuring CEO's of the leading pharmaceutical companies working in Russia, will share their thoughts on the future of market development, the needs of the business for the next decade, as well as analysing the most critical elements to any growth strategy.

• INTERACTIVE PANEL DISCUSSION ON KEY LEGAL ISSUES IN THE RUSSIAN PHARMACEUTICAL SECTOR
This session will gather together experts from the leading legal companies specialising in pharmaceutical market to debate the practical problems that companies and legal counsels face in their day-to-day business and examine a variety of issues in commercial and contract law that affect company operations and profitability. Topics for discussion include: unfair competition, data protection and data exclusivity, advertising and promotion, pricing and subsidies, and many others.